PATENT CLAIM ANALYSIS

Application Number: 16274271
Application Type: Utility
Filing Date: 2019-02
Publication Date: 2019-08
Patent Classification: ["514", "002700"]

Abstract:
The inventors provide a composition comprising an antimicrobial polypeptide comprising Blad or an active variant thereof for use in a method of treatment of the human or animal body by therapy or prophylaxis, such as for use in a method of treating or preventing an infection in or on a subject by a microorganism. Also provided is the use of a composition comprising an antimicrobial polypeptide comprising Blad or an active variant thereof to kill, or inhibit the growth of, a microorganism that is pathogenic to a human or an animal at a site that is not on or in the human or animal body.

Claim (Index 18):
A method of treating a human or animal comprising administering to a subject in need thereof a composition comprising a therapeutically effective amount of an antimicrobial polypeptide comprising the Blad sequence shown in SEQ ID NO:4 or an active variant thereof, wherein said active variant has antimicrobial activity and comprises a sequence which has at least 60% amino acid identity to either SEQ ID NO:4 or a fragment of SEQ ID NO:4.

Metadata:
- Claim Count in Document: 44.0
- Percentile: 99.0
- Lexical Diversity: 2.2449
- Patent Class: 514.0
- Transitional Phrase Type: open
- Component Type: 1
- Foreign Priority: True
- Related Applications: ['13879151', '14752984', '13879162', '13416793', '12294000']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.75081996418068
- 35 USC 102 Novelty (BERT): 0.5512693768769731
- Combined Prediction Score: 0.7308649054503092
- Mean Citation Score: 270.992594
- Max Citation Score: 430.85516
- Similarity Product: 303.0345582321024

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 0
- Claim Label 112: 0
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test